Myopia Progression: Clinical Trials

33 trials for Myopia Progression, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 recruiting, 7 active not recruiting, 6 completed, 5 not yet recruiting. 21 Not applicable, 4 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable21Active not recruiting 6, Recruiting 5, Completed 4, Not yet recruiting 4, Enrolling by invitation 1, Unknown 1
Phase 34Recruiting 2, Active not recruiting 1, Completed 1
Phase 23Unknown 3

Follow Myopia Progression: new trials by email Literature Review of Myopia Progression trials Research Report on Myopia Progression

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparing Myopia Control Spectacle Lenses and Standard Single Vision Spectacle Lenses in Children With Myopia
Investigational Myopia Control Spectacle Lens, Single Vision Spectacle Lens - Myopia, Myopia Progression
Not applicableNot yet recruitingEssilor International202026-10-012026-09-24
Contact Lenses to Slow Myopia Progression in Adults
Dual Focus Soft Contact Lens, Single Vision Soft Contact Lens - Myopia, Myopia Progression
Not applicableNot yet recruitingUniversity of California, Berkeley1522026-09-012026-08-05
Inhibition of Myopia Progression With Optical Devices
Wearing myopia-control D.I.M.S. glasses while awake, DIMS (Defocus Incorporated Multiple Segments) lenses - Myopia Progression, Myopia
RecruitingSemmelweis University502026-06-022026-07-13
Prospective Research on the Intervention of Myoless2.0 Effectiveness (PRIME) in Pediatric Population
myopia control lens - Myopia Progression
Not yet recruitingIndizen Optical Technologies, S.L.U.1802026-04-012026-03-05
The Effect of Myopia-Control Contact Lenses in New Zealand Chinese Children
MiSight Contact Lenses (CooperVision), Albiliti 1-Day (Johnson and Johnson, VisionCare) - Myopia Progression
Phase 3Active not recruitingAston University662026-03-212026-09-04
Evaluation of the Effectiveness of a New Generation of Myopia Control Lens on the Progression of Myopia in Children Aged 6 to 14 Years
MCL1, MCL2 - Myopia Progression
Not applicableRecruitingEssilor International762026-03-182026-04-23
Mobility Performance in Daily Activities Among Children Wearing Spectacle Lenses
Novel spectacle lens design, Spectacle lenses - Myopia, Myopia Progression
Not applicableRecruitingSightGlass Vision, Inc.202026-02-022026-04-30
Myopia Progression Control Using Atropine 0.05% After Pediatric Cataract Surgery And Intraocular Lens Implantation Surgery
Atropine Eye drops - Pediatric Cataract, IOL Implantation
Not applicableNot yet recruitingCairo University502026-02-012026-01-23
Children's Viewing Behavior
Novel spectacle lens design, Spectacle lenses - Myopia, Myopia Progression
Not applicableRecruitingSightGlass Vision, Inc.202025-12-222026-04-30
Management of Myopia in University Students With DIMS-TED Spectacle Lenses
DIMS TED spectacle lenses, Single vision spectacle lenses - Myopia Progression
Not applicableEnrolling by invitationUniversity of Bradford382025-10-012026-07-13
Atropine in the Treatment of Myopia Study in Malaysia
Low dose atropine sulfate eye drops, Placebo - Myopia Progression
Phase 3RecruitingIDB VisionCare SDN BHD1442025-09-172026-01-09
The A.R.R.E.S.T.® Contact Lens Study
Single-vision contact lens, A.R.R.E.S.T.® contact lens - Myopia, Myopia Progression
Not applicableActive not recruitingnthalmic Pty Ltd802025-07-062026-07-31
The A.R.R.E.S.T.® Spectacle Film Study
Single vision spectacle lens, A.R.R.E.S.T. spectacle film - Myopia, Myopia Progression
Not applicableActive not recruitingnthalmic Pty Ltd1232025-04-122026-05-20
Evaluation of Performance of MiYOSMART Photochromic and Clear Spectacle Lenses in Myopic Children
EYE001 - Myopia, Myopia Progression
Not applicableNot yet recruitingSingapore National Eye Centre2022025-01-022024-12-04
Optimizing Light Exposure for Myopia Prevention and Control (LightSPAN)
Light Intervention, Digital Intervention, Control Group - Myopia, Light; Therapy, Complications
Not applicableRecruitingNational University of Singapore3962024-10-212025-09-23
Study on the Impact of Desk and Chair Adaptation Intervention on the Occurrence and Development of Myopia in Primary School Students
Desk and chair adaptation interventions - Axial Length, Eye, Myopia
Not applicableUnknownFangbiao Tao21002024-10-012024-10-02
The P.A.U.S.E.® Spectacle Study
Single vision spectacle lens, P.A.U.S.E. spectacle lens 1, P.A.U.S.E. spectacle lens 2 - Myopia, Myopia Progression
Not applicableActive not recruitingnthalmic Pty Ltd2052024-09-142026-05-20
Low Dose Atropine Eye Drops in Myopic Egyptian Children
low dose atropine eye drops, Placebo - Myopia Progression, Axial Length, Eye
Phase 2UnknownAin Shams University752024-09-012024-02-20
The Effectiveness and Safety of Two Low-concentration Atropine Sulfate Eye Drops (0.01%/0.02%) for Delaying the Pediatric Myopia Progression
Atropine sulfate eye drops 0.01%, Atropine sulfate eye drops 0.02%, Placebo eye drops - Myopia, Myopia Progression
Phase 3RecruitingOupushifang Pharmaceutical Technology Co., Ltd.6062024-06-152024-12-24
Efficacy and Safety of 0.01%, 0.03%, and 0.05% Atropine Eye Drops in Reducing Myopia Progression
Atropine sulphate eye drop 0.01%, Atropine sulphate eye drop 0.03%, Atropine sulphate eye drop 0.05% - Myopia Progression, Atropine
Phase 3CompletedKhyber Medical College, Peshawar952024-06-032026-06-10

Showing 20 of 33. Sign in to see all of them.

Narrower conditions

Myopia (20)  ·  Refractive Errors (2)  ·  Intraocular Lymphoma (1)  ·  Myopia, Degenerative (1)

Broader conditions

Eye Diseases (20)  ·  Refractive Errors (18)  ·  Eye Neoplasms (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Lymphatic Diseases (1)  ·  Lymphoma (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)

Interventions

Lenses (2)  ·  Atropine (1)  ·  Control Groups (1)

Sponsors

SightGlass Vision, Inc. (6)  ·  nthalmic Pty Ltd (3)  ·  Beijing Tongren Hospital (2)  ·  Essilor International (2)  ·  Ain Shams University (1)  ·  Aston University (1)  ·  Benha University (1)  ·  Cairo University (1)  ·  Central Hospital, Nancy, France (1)  ·  Chang Gung Memorial Hospital (1)  ·  Ege University (1)  ·  Fangbiao Tao (1)  ·  IDB VisionCare SDN BHD (1)  ·  Illinois College of Optometry (1)  ·  Indizen Optical Technologies, S.L.U. (1)

Countries

United States (7)  ·  China (3)  ·  Egypt (3)  ·  Singapore (3)  ·  France (2)  ·  Malaysia (2)  ·  Spain (2)  ·  United Kingdom (2)  ·  Vietnam (2)  ·  Argentina (1)  ·  Canada (1)  ·  Hungary (1)  ·  New Zealand (1)  ·  Pakistan (1)  ·  Portugal (1)

Top investigators

Andrew Tan (1)  ·  Aya Mahmoud, Master's (1)  ·  Cheryl Hill (1)  ·  Daniel Tilia, MOptom, PhD (1)  ·  Kathryn Webber, MOptom (1)  ·  Nazli Gul, FCPS (1)  ·  Neema Ghorbani-Mojarrad, PhD (1)  ·  Niall Hynes, PhD (1)  ·  Ningli Wang, PhD (1)  ·  Ningli Wang, Postdoctoral (1)  ·  Pei-Chang Wu, MD,PhD (1)  ·  Ranjila Shyangbo (1)  ·  Raymond P. Najjar, PhD (1)  ·  Sarah Singh (1)  ·  Sophie Coverdale, PhD (1)

Results publications

PMID 10548123, PMID 15623754, PMID 16877074, PMID 23672971, PMID 24099276, PMID 24160405, PMID 25655799, PMID 25719391, PMID 25837970, PMID 26372583, PMID 28894238, PMID 28951126, PMID 30817826, PMID 32231278, PMID 33443542, PMID 34958689, PMID 41222872, PMID 41875210, PMID 42850035